Shionogi & Co., Ltd. (SGIOF)
PNK · Healthcare · Drug Manufacturers - Specialty & Generic
Closing price as of 2026-10-27 · Source: TEK2day Finance
Key Metrics
About Shionogi & Co., Ltd.
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.
Quarterly Financials (JPY)
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 113.2B | 147.7B | 139.0B | 163.3B |
| Gross Profit | 96.2B | 122.6B | 110.9B | 132.5B |
| Operating Income | 39.7B | 73.9B | 18.0B | 66.9B |
| Net Income | 44.2B | 74.7B | 47.0B | 97.7B |
| Diluted EPS | JPY 114.78 |
Annual Financials (JPY)
| Metric | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 426.7B | 435.1B | 438.3B | 499.7B |
| Gross Profit | 364.4B | 377.5B | 374.4B | 417.2B |
| Operating Income | 149.0B | 153.3B | 156.6B | 166.7B |
| Net Income | 185.0B | 162.0B | 170.4B | 205.2B |
| Diluted EPS | JPY 207.03 | JPY 186.11 | JPY 200.29 | JPY 241.04 |